ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case

September 26, 2014

Sieving Named Director, National Eye Insitute.

January 19, 2001

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

June 6, 2003

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

October 3, 2014

NCI, Litton Open Talks On Frederick Contract

February 6, 1976

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010